August J Moretti insider trades: Depomed (DEPO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where August reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 14, 2016 | DEPO | ↓ Sell10b5-1 | 5,000 | $20.84 | $104K | Direct | Nov 15, 2016 (1d) |
| Aug 10, 2016 | DEPO | ↓ Sell10b5-1 | 3,297 | $21.40 | $71K | Direct | Aug 11, 2016 (1d) |
| Aug 10, 2016 | DEPO | ↓ Sell10b5-1 | 1,703 | $21.40 | $36K | Direct | Aug 11, 2016 (1d) |
| May 9, 2016 | DEPO | ↓ Sell10b5-1 | 5,000 | $18.00 | $90K | Direct | May 9, 2016 (0d) |
| Dec 3, 2015 | DEPO | ↓ Sell10b5-1 | 15,000 | $18.11 | $272K | Direct | Dec 3, 2015 (0d) |
| Dec 2, 2014 | DEPO | ↓ Sell10b5-1 | 5,339 | $15.85 | $85K | Direct | Dec 3, 2014 (1d) |
| Dec 2, 2013 | DEPO | ↓ Sell10b5-1 | 2,821 | $8.40 | $24K | Direct | Dec 4, 2013 (2d) |
| May 5, 2010 | ALXA | ↓ Sell | 10,000 | $3.50 | $35K | Direct | May 7, 2010 (2d) |
| Dec 18, 2009 | ALXA | ↓ Sell | 14,009 | $2.23 | $31K | Direct | Dec 18, 2009 (0d) |
| Apr 1, 2008 | ALXA | ↓ Sell10b5-1 | 5,000 | $7.17 | $36K | Direct | Apr 2, 2008 (1d) |
| Jan 2, 2008 | ALXA | ↓ Sell10b5-1 | 5,000 | $7.89 | $39K | Direct | Jan 3, 2008 (1d) |
| Oct 1, 2007 | ALXA | ↓ Sell10b5-1 | 5,000 | $8.59 | $43K | Direct | Oct 3, 2007 (2d) |
| Aug 1, 2007 | ALXA | ↓ Sell10b5-1 | 5,000 | $8.66 | $43K | Direct | Aug 1, 2007 (0d) |
| Apr 2, 2007 | ALXA | ↓ Sell10b5-1 | 10,000 | $12.37 | $124K | Direct | Apr 3, 2007 (1d) |
| Dec 7, 2006 | ALXA | ↓ Sell | 2,000 | $8.30 | $17K | Direct | Dec 8, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About August J Moretti's insider trades
August J Moretti is Chief Financial Officer & SVP at Depomed (DEPO). Since Dec 7, 2006, August has reported no open-market purchases and 15 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
12 sales (92% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (26 filings), option exercises (13 filings), shares withheld for taxes (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DEPO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.